People struggling with many addictions, ranging from opioids to gambling, are reporting similar experiences in clinics, on ...

A study of more than 600,000 veterans found that GLP-1 drugs — originally designed for diabetes and weight loss — cut ...

A study of 600,000+ veterans found GLP-1 drugs like Ozempic reduced substance-related deaths by 50% across alcohol, opioids, cocaine, nicotine, and cannabis — making them the first medication class to ...

A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce ...

GLP-1 medications may quiet the brain signals behind addiction, reducing substance use disorders and overdose risk across ...

Research suggests the drugs have potential for prevention and harm reduction in substance use disorders, writes Ziyad Al-Aly People taking glucagon-like peptide-1 (GLP-1) receptor agonists often ...

Rutgers researchers have used neuroimaging to demonstrate that cocaine addiction alters the brain's system for evaluating how rewarding various outcomes associated ...

Scientists identify the protein DeltaFosB as the "master switch" that rewires the brain's memory and reward circuits, driving chronic cocaine addiction and relapse.

Studies suggest GLP-1 drugs like Semaglutide and Tirzepatide may help reduce cravings for alcohol, opioids, and nicotine. Researchers say these medications influence the brain’s reward system, ...

Researchers report October 25 in the journal Neuron that cocaine addiction disrupts the dopamine neurons that govern how we perceive and learn from rewards. Though people with cocaine addiction have ...

Tracking over 600,000 veterans shows that GLP-1 receptor agonists are linked to lower rates of substance use disorders, fewer overdoses, and fewer addiction-related hospital visits.

Why do so many people relapse after quitting cocaine? A new study from The Hebrew University reveals that a specific "anti-reward" brain circuit becomes hyperactive during withdrawal-driving ...